Home  >  Community Q&A: “Have we made the discovery of a generation?”  >  Community Q&A: “Have we made the discovery of a generation?”

Have we made the discovery of a generation? A drug that unblocks life-threatening clogged arteries 

 

Cardiovascular disease is still the number one disease killer with over 18 million people around the globe dying from it each year.  

Accounting for 32% of deaths worldwide, the leading cause of these deaths is the build-up of the fat deposits in our blood vessels that obstruct blood flow to vital organs, also known as plaque.  

Did you know that 1 in 5 Australians are diagnosed with Peripheral Arterial Disease – a build-up of plaque in blood vessels that leads to pain and immobility and, if left unchecked gangrene and finally limb amputation? 1 Australian has a PAD-related amputation every 3 hours.  

No drug has been found to reduce plaque – until now 

In what could be a discovery of a generation, this new drug has been designed specifically for PAD but has transformational implications for the treatment of cardiovascular disease – one of the highest cost medical conditions in the world.  

To learn more about this incredible discovery, please join us on Monday 22 August for an incredible Community Q&A: 

 

Have we made the discovery of a generation? 

A drug that unblocks life-threatening clogged arteries 

 

Hear directly from the brilliant minds at the Perkins as they share how this new drug was discovered and what it means for the future of patients with peripheral artery disease (PAD) – a common disease of plaque build-up in the lower legs.  

When: Monday 22 August 6:00PM – 7:30PM (AWST) 

Where: McCusker Auditorium, Harry Perkins Institute of Medical Research, 6 Verdun Street, Nedlands (find parking here).

Cost: Free 

Panellists:  

  • Associate Professor Juliana Hamzah – Head of Laboratory Targeted Drug Delivery, Imaging and Therapy  
  • Professor Shirley Jansen – Head of Vascular Surgery at Sir Charles Gairdner Hospital 
  • Mr Trevor Jones – PAD Amputee Patient
  • Mr John Barrington AM – Co-founder and Managing Director of Artrya Ltd, Chair of the Perkins Board. 
  • Hosted by Miriam Borthwick, Perkins Senior Media Advisor and former Senior Reporter for The 7:30pm Report. 

Audience members will have an opportunity to participate in the conversation and ask questions to all panel members who will be present after the discussion for a Q&A session.  

RSVP here now save your seat!  

Date and time

Monday 22 August 2022, 6pm – 7.30pm

.

Cost

FREE

Location

Harry Perkins Institute of Medical Research, 6 Verdun Street, Nedlands

RSVP